Charles River Laboratories International

Charles River Laboratories, Inc., is a corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries. The Company also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. Charles River Laboratories' customers include pharmaceutical and biotechnology companies as well as academic institutions and government research centers. 

Company Growth (employees)
Wilmington, US
Size (employees)
11,000 (est)+28%
Charles River Laboratories International was founded in 1947 and is headquartered in Wilmington, US

Charles River Laboratories International Office Locations

Charles River Laboratories International has an office in Wilmington
Wilmington, US (HQ)
251 Ballardvale Street

Charles River Laboratories International Data and Metrics

Charles River Laboratories International Financial Metrics

Charles River Laboratories International's revenue was reported to be $1.7 b in FY, 2016 which is a 23% increase from the previous period.

Revenue (FY, 2016)

1.7 b

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

1.4 b

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

156.4 m

EBIT (FY, 2016)

237.4 m

Market capitalization (20-Jul-2017)

4.8 b

Closing share price (20-Jul-2017)


Cash (31-Dec-2016)

117.6 m
Charles River Laboratories International's current market capitalization is $4.8 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


1.2 b1.3 b1.4 b1.7 b

Revenue growth, %


Cost of goods sold

264 m277 m

Gross profit

671.4 m739.1 m1.1 b1.4 b

Gross profit Margin, %


General and administrative expense

367.5 m

Operating expense total

367.5 m


151.4 m177.7 m206.4 m237.4 m

EBIT margin, %


Interest expense

15.1 m27.7 m

Interest income

1 m1.3 m

Income tax expense

43.4 m66.8 m

Net Income

104.2 m128.4 m151.1 m156.4 m
USDFY, 2013FY, 2014FY, 2015FY, 2016


155.9 m160 m117.9 m117.6 m

Accounts Receivable

220.6 m258 m270.1 m364.1 m


89.4 m89 m93.7 m95.8 m

Current Assets

552.6 m606.9 m559.2 m656.8 m


676.2 m676.8 m678 m755.8 m


230.7 m321.1 m438.8 m787.5 m

Total Assets

1.6 b1.9 b2.1 b2.7 b

Accounts Payable

31.8 m33.8 m36.7 m68.5 m

Current Liabilities

247 m296.2 m311.8 m429.6 m

Total Liabilities

1.9 b

Additional Paid-in Capital

2.2 b2.3 b2.4 b2.5 b

Retained Earnings

(265.5 m)(138.8 m)10.5 m165.3 m

Total Equity

664.7 m737.6 m839.1 m

Financial Leverage

2.5 x2.8 x3.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

104.2 m128.2 m151.1 m156.4 m

Depreciation and Amortization

96.6 m96.4 m24.2 m41.7 m

Accounts Receivable

(17 m)(52.8 m)


(1.6 m)(3 m)3.4 m(4 m)

Accounts Payable

(7.1 m)4.6 m1.2 m22.1 m

Cash From Operating Activities

209 m252.1 m288.2 m300.4 m

Capital Expenditures

39.2 m(56.9 m)(63.3 m)(55.3 m)

Cash From Investing Activities

(74 m)(298 m)(320.3 m)(686.4 m)

Cash From Financing Activities

(84.2 m)61.4 m4.5 m390.7 m

Interest Paid

12 m10.2 m11.1 m22.8 m

Income Taxes Paid

19.1 m29.7 m24.4 m42.9 m

Free Cash Flow

169.9 m309.1 m351.5 m245.1 m
USDY, 2016


195.5 k

Financial Leverage

3.2 x

Charles River Laboratories International Market Value History

Charles River Laboratories International Online and Social Media Presence

Charles River Laboratories International News and Updates

Charles River Laboratories International Company Life and Culture

You may also be interested in